Literature DB >> 9713994

Frequent rearrangements of chromosomes 1, 7, and 8 in primary liver cancer.

L A Parada1, M Hallén, K G Tranberg, I Hägerstrand, L Bondeson, F Mitelman, B Johansson.   

Abstract

Fifteen primary liver carcinomas (PLCs), including 12 hepatocellular carcinomas and three cholangiocellular carcinomas, were investigated cytogenetically after short-term culture. Ten tumors displayed clonal chromosomal abnormalities, whereas only normal karyotypes were detected in four cases, and one sample failed to grow in vitro. Structural rearrangements most often involved chromosomes 1, 7, and 8 and chromosome bands 1p36, 1q25, 3q10, 5q13, 6p10, 7p15, 7q22, 7q32, 8q10, 8q13, 14q10, and 17p11. Frequent genomic imbalances included gains of 1q, 3q, 6p, 7p, and 8q and losses of 1p, 8p, 10q, 14p, 17p, and 19p. A compilation of findings for all 19 cytogenetically abnormal PLCs reported to date, including the present cases, reveals that structural aberrations particularly affect 1p11, 1p22, 1p32, 1p34, 1p36, 1q25, 7p15, 7q22, 8q10, 8q13, 14q10, 16q24, and 17p11, and that the abnormalities frequently result in overrepresentation of 1q, 3q, 6p, 7p10-14, 8q, and 17q and underrepresentation of 1p34-36, 6q27, 7q32-qter, 8p, 13p, 14p, 16q24, and 17p. These genomic regions are likely to harbor genes of importance in hepatocarcinogenesis, and the present cytogenetic mapping may hence be of value for further molecular genetic investigations of PLC.

Entities:  

Mesh:

Year:  1998        PMID: 9713994     DOI: 10.1002/(sici)1098-2264(199809)23:1<26::aid-gcc5>3.3.co;2-g

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  11 in total

1.  Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5.

Authors:  X Zhou; V M Richon; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 2.  ZAS: C2H2 zinc finger proteins involved in growth and development.

Authors:  Lai-Chu Wu
Journal:  Gene Expr       Date:  2002

3.  Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA.

Authors:  Jie Ding; Shenglin Huang; Shunquan Wu; Yingjun Zhao; Linhui Liang; Mingxia Yan; Chao Ge; Jian Yao; Taoyang Chen; Dafang Wan; Hongyang Wang; Jianren Gu; Ming Yao; Jinjun Li; Hong Tu; Xianghuo He
Journal:  Nat Cell Biol       Date:  2010-03-21       Impact factor: 28.824

4.  Hepatomegaly in transgenic mice expressing the homeobox gene Cux-1.

Authors:  Gregory B Vanden Heuvel; Jennifer G Brantley; Neal I Alcalay; Madhulika Sharma; Gabor Kemeny; Joshua Warolin; Aric W Ledford; David M Pinson
Journal:  Mol Carcinog       Date:  2005-05       Impact factor: 4.784

5.  Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma.

Authors:  N Wong; W C Lam; P B Lai; E Pang; W Y Lau; P J Johnson
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

6.  TRIM proteins and cancer.

Authors:  Shigetsugu Hatakeyama
Journal:  Nat Rev Cancer       Date:  2011-10-07       Impact factor: 60.716

7.  Cytogenetic analyses of secondary liver tumors reveal significant differences in genomic imbalances between primary and metastatic colon carcinomas.

Authors:  L A Parada; A Marañon; M Hallén; K G Tranberg; U Stenram; G Bardi; B Johansson
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

8.  Predominant modifier of extreme liver cancer susceptibility in C57BR/cdJ female mice localized to 6 Mb on chromosome 17.

Authors:  Stephanie E-M Peychal; Andrea Bilger; Henry C Pitot; Norman R Drinkwater
Journal:  Carcinogenesis       Date:  2009-03-02       Impact factor: 4.944

Review 9.  The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update.

Authors:  Ming Liu; Lingxi Jiang; Xin-Yuan Guan
Journal:  Protein Cell       Date:  2014-06-11       Impact factor: 14.870

10.  Methylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3.

Authors:  Ling Xu; Weiqi Dai; JingJing Li; Lei He; Fan Wang; Yujing Xia; Kan Chen; Sainan Li; Tong Liu; Jie Lu; Yingqun Zhou; Yugang Wang; Chuanyong Guo
Journal:  Oncotarget       Date:  2016-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.